Literature DB >> 30055543

Nanotechnology: An Emerging Therapeutic Option for Breast Cancer.

Zulfia Hussain1, Junaid Ali Khan1, Sehrish Murtaza1.   

Abstract

The pharmacological application of nanodevices and systems is a rapidly emerging nanotechnology that is raising new possibilities in the diagnosis and therapy of different diseases. Nanotechnology has been providing promising tools for chemotherapy especially in cancer treatment. Nanotechnology deals with physical and biochemical properties of nanoparticles in the clinical application of drugs. Targeted nanoparticle drug delivery is intended to reduce the side effects of anticancer drugs with both decreases in consumption and treatment expenses, which are the major hurdles in conventional cancer treatment. The characteristic small size and special coating of nanoparticles facilitates the delivery of hydrophobic anticancer drugs to specific sites with reduced opsonization by defense mechanisms of the body. One of the vast applications of nanotechnology is the diagnosis, treatment, and prevention of breast cancers. Breast cancer is associated with high morbidity and mortality and is the second leading cause of death in Western countries. A large number of nanoparticles have been developed, specifically targeting metastasized tumors of the breast. The present review focuses on the application of different types of nanoparticles including gold, polymeric, and magnetic nanoparticles in the treatment of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30055543     DOI: 10.1615/CritRevEukaryotGeneExpr.2018022771

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  6 in total

1.  Formulation and Evaluation of Apigenin-Loaded Hybrid Nanoparticles.

Authors:  Imran Kazmi; Fahad A Al-Abbasi; Syed Sarim Imam; Muhammad Afzal; Muhammad Shahid Nadeem; Hisham N Altayb; Sultan Alshehri
Journal:  Pharmaceutics       Date:  2022-04-03       Impact factor: 6.525

2.  Variations in the Gut Microbiota in Breast Cancer Occurrence and Bone Metastasis.

Authors:  Yu Wenhui; Xie Zhongyu; Chen Kai; Cai Zhaopeng; Li Jinteng; Ma Mengjun; Su Zepeng; Che Yunshu; Wang Peng; Wu Yanfeng; Shen Huiyong
Journal:  Front Microbiol       Date:  2022-05-26       Impact factor: 6.064

3.  Mechanisms of Drug Resistance and Use of Nanoparticle Delivery to Overcome Resistance in Breast Cancers.

Authors:  Huseyin Beyaz; Hasan Uludag; Doga Kavaz; Nahit Rizaner
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Immunotherapy: A Challenge of Breast Cancer Treatment.

Authors:  Marilina García-Aranda; Maximino Redondo
Journal:  Cancers (Basel)       Date:  2019-11-20       Impact factor: 6.639

Review 5.  A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers.

Authors:  Safiye Akkın; Gamze Varan; Erem Bilensoy
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

Review 6.  Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review.

Authors:  Yosif Almoshari
Journal:  Pharmaceutics       Date:  2022-03-09       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.